Wall Street Zen upgraded shares of Cellebrite DI (NASDAQ:CLBT – Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday morning. Get Cellebrite DI alerts:Check Out Our Latest Stock Report on Cellebrite DICellebrite DI Stock Up 1.8%CLBT opened at $18.63 on Friday. On average, analysts expect that Cellebrite DI will post 0.3 earnings per share for the current fiscal year. Cellebrite DI Company Profile(Get Free Report)Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Recommended StoriesReceive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.